These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38266453)

  • 1. Study on tissue distribution, metabolite profiling, and excretion of [
    Ma Z; Tang M; Chen L
    J Pharm Biomed Anal; 2024 Apr; 241():115984. PubMed ID: 38266453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPLC-MS/MS method development and application to pharmacokinetic study in rats and dogs of Flonoltinib Maleat.
    Ma Z; Tang M; Pu Q; Wei P; Wu R; Zhao J; Zhou Y; Yang Z; Ye H; Chen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123696. PubMed ID: 37086507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2
    Hu M; Yang T; Yang L; Niu L; Zhu J; Zhao A; Shi M; Yuan X; Tang M; Yang J; Pei H; Yang Z; Chen Q; Ye H; Niu T; Chen L
    Blood Cancer J; 2022 Mar; 12(3):37. PubMed ID: 35256594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism, and excretion of [¹⁴C]GDC-0449 (vismodegib), an orally active hedgehog pathway inhibitor, in rats and dogs: a unique metabolic pathway via pyridine ring opening.
    Yue Q; Chen YH; Mulder T; Deese A; Takahashi R; Rudewicz PJ; Reynolds M; Solon E; Hop CE; Wong H; Khojasteh SC
    Drug Metab Dispos; 2011 Jun; 39(6):952-65. PubMed ID: 21363998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.
    Liu Y; Yao X; Song L; Liu H; Zhao Q; Jiang J; Ni G; Shi C; Ma X; Zhou H; Liu D; Hu P
    J Pharm Biomed Anal; 2018 Aug; 157():189-200. PubMed ID: 29803910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of [3H]triptolide and its metabolites in rats after oral administration.
    Liu J; Zhou X; Chen XY; Zhong DF
    Acta Pharmacol Sin; 2014 Apr; 35(4):549-54. PubMed ID: 24632843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects.
    Darwish M; Nunez R; Youakim JM; Robertson P
    Clin Drug Investig; 2024 Jan; 44(1):21-33. PubMed ID: 38017349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of berberine and its metabolites in oral administration in rats.
    Ma JY; Feng R; Tan XS; Ma C; Shou JW; Fu J; Huang M; He CY; Chen SN; Zhao ZX; He WY; Wang Y; Jiang JD
    J Pharm Sci; 2013 Nov; 102(11):4181-92. PubMed ID: 24006193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers.
    Reif S; Schultze-Mosgau MH; Engelen A; Piel I; Denner K; Roffel A; Tiessen R; Klein S; Francke K; Rottmann A
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):71-85. PubMed ID: 38044419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
    Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
    J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring in vivo metabolism and excretion of QO-58L using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
    Zhang J; Jia Q; Qi J; Zhang H; Wu Y; Shi X
    Eur J Pharm Sci; 2018 May; 117():379-391. PubMed ID: 29452212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats.
    Zheng YT; Zhu JH; Ma G; Zhu Q; Yang P; Tan B; Zhang JL; Shen HX; Xu JL; Zhu YZ; Cai WM
    Acta Pharmacol Sin; 2012 Jun; 33(6):839-44. PubMed ID: 22543704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, metabolism, and excretion of cycloastragenol, a potent telomerase activator in rats.
    Ma PK; Wei BH; Cao YL; Miao Q; Chen N; Guo CE; Chen HY; Zhang YJ
    Xenobiotica; 2017 Jun; 47(6):526-537. PubMed ID: 27412909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UPLC-ESI-Q-TOF/MS Based Metabolic Profiling of Protosappanin B in Rat Plasma, Bile, Feces, Urine and Intestinal Bacteria Samples.
    Chen WY; Liang GY; Zheng ZL; Wu YS; Xu FF; Liu B; Guo DA
    Curr Drug Metab; 2021; 22(6):491-499. PubMed ID: 33605854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.